In a mouse model of colitis, neutralization of IL-23 using an IL-23-specific anti-p19 antibody significantly alleviated both emerging and established colitis, through the downstream inhibition of IL-17 expression, leading to diminished neutrophil infiltration (37). The gene discussed is IL17A; the disease is colitis.